Association of clinical characteristics with the use of proteomic testing for lung nodule malignancy risk stratification at a safety-net hospital. Event-free survival (EFS) by PDL-L1 TPS subgroup.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback